AstraZeneca’s release Monday of encouraging data about its coronavirus vaccine from its U.S. trial raised hopes that the drug company could put a troubled rollout behind it. But just hours after its announcement, American officials issued an unusual statement expressing concern the company had included “outdated information” from its study and that it may have provided “an incomplete view of the efficacy data.”
Related posts
-
Barnes & Noble nears return to downtown Naperville
Barnes & Noble is opening a new Naperville store on Wednesday, April 23, in a former... -
Four men charged in connection with residential burglary in Long Grove
Four men were jailed after being charged in connection with a burglary at a Long Grove... -
Shop local during Made in Elgin Spring Pop-Up Market Saturday
You can shop locally for things produced locally during the Made in Elgin Spring Pop-Up Market...